The move to the LSE's Main Market from the AIM reflects the scale and maturity achieved through GlobalData’s long-term strategy.

Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles, marking one of the largest AI partnerships in the pharma industry to date. According to ...

Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.

The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support. For too long, specialty ...

New drugs and lucrative markets in the US remain crucial to Europe’s pharma sector, as governments approach closer trade with Asia.

Márcio Temtem, Hovione, discusses how his company integrates modular hardware and modeling software to accelerate pharmaceutical R&D and optimize manufacturing processes. Márcio Temtem, vice president ...

At Sun Pharma, what do you lead in the drug delivery space? I lead drug delivery device development ranging from pen injectors, autoinjectors, pre-filled syringes, nasal sprays, inhalers, ophthalmic ...

Define Ventures’ new report provides a clear framework for how enterprise healthcare, particularly Big Pharma, is transitioning from AI exploration to execution. It focuses on core categories, ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited has recently signed a cooperation agreement with a leading technology-driven e-commerce platform serving ...

Novo Nordisk was a pioneer in developing GLP-1 drugs for metabolic disorders, but its products are still mainly once-weekly injections. The Danish pharmaceutical giant is putting up $285 million to ...